McKinsey Targeted by School Districts Over Opioid-Related Costs
(Bloomberg) -- McKinsey & Co. faces Kentucky and West Virginia school districts' lawsuits alleging the company's work for opioid makers fed an epidemic that harmed children and drove up educational costs, in the first such cases by educators against the consulting firm.
McKinsey's advice to opioid makers such as Purdue Pharma LP on ramping up sales of the highly addictive painkillers made it the “primary architect” of marketing campaigns that resulted in millions of opioid users' addictions over the last 20 years, the suit on behalf of more than 170 Kentucky school districts says.
Those ailments led to a jump in the numbers of special-need students resulting from in-utero opioid addictions, forcing districts across the U.S. to spent billions for extra supports, according to the suits, filed this week.
“Because of the defendant's egregious wrongdoing, for the last two decades, public schools have been shouldering a most profound and enduring consequence of the nationwide opioid epidemic,” according to the Kentucky complaint.
McKinsey Deal
The suits come in the wake of McKinsey's decision this year to pay $641 million to U.S. states to settle claims over its opioid consulting work. Local governments sued, fearing they will be denied a payout from the deal.
“We believe the settlement we entered into with the states also resolves claims that may be brought by municipalities or school districts,” DJ Carella, a McKinsey spokesman, said Thursday in an emailed statement.
Some state attorneys general argue that McKinsey's accord provides funds to combat opioid addictions and address the fallout from overdose deaths. Researchers have found more than 400,000 Americans died of opioid-related overdoses over the last 20 years.
The West Virginia suit accuses McKinsey of helping to create a public nuisance by working with manufactures to help flood the state with painkillers. The firm's opioid consulting led to a spike in cases of Neonatal Abstinence Syndrome, which left babies addicted to opioids in the womb, according to the suit. The condition often produces students that need “extra interventions and supports throughout their education,” the suit said.
“The number of these children has increased exponentially since the onslaught of the opioid epidemic and shows no signs of slowing,” West Virginia educators argue.
A federal judge in Charleston, West Virginia, is now hearing evidence in an opioid case against the largest U.S. drug distributors brought by two municipalities.
The West Virginia case is Board of Education of Mason County v. McKinsey & Co., 21-cv-00280, U.S. District Court, Southern District of West Virginia (Huntington). The Kentucky case is Board of Education of Jefferson County v. McKinsey & Co., 21-cv-282, U.S. District Court, Western District of Kentucky (Louisville).
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.